UCB SA Logo

UCB SA (UCBJF)

OTC

Currency in USD
263.09
+3.99 (+1.54%)

Closed

Aug 21, 2026

Day's Range

263.09
263.09

52 wk Range

225.65
345.39

Overview - UCBJF - UCB SA

Key Statistics

Valuation

Enterprise Value

62.00B

P/E (Trailing)

‪19.91‬

Price / Sales (TTM)

‪5.88‬

Price / Book

‪4.05‬

EV / EBITDA

‪15.85‬

Profitability

Profit Margin

‪25.73%‬

Operating Margin

‪33.32%‬

Return on Assets

‪8.97%‬

Return on Equity

‪20.56%‬

Ownership

Shares Outstanding

190.66M

Float

120.15M

Held by Insiders

‪36.27%‬

Held by Institutions

‪38.55%‬

Price stats

Beta

‪0.18‬

50-Day Avg

‪282.33‬

200-Day Avg

‪291.92‬

Dividends

Payout Ratio

‪12.81%‬

Frequency

Annual

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - UCBJF - UCB SA

Peers - UCBJF - UCB SA

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - UCBJF - UCB SA

About

UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Parkinson's disease, Crohn's disease, psoriasis, and autoimmune…

SectorHealthcare
IndustryBiotechnology
Employees9.76K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.